Where the free help actually lives

The CDC page on quitting, last reviewed September 27, 2024, lists these access points. All of them are public services rather than commercial programs.

1. 1 1 800 QUIT NOW (1 800 784 8669) connects you to your state's quitline for free telephone coaching.
2. 2 Spanish speakers can call 1 855 DEJELO YA (1 855 335 3569). CDC also lists 1 800 838 8917 for Chinese, 1 800 556 5564 for Korean, and 1 800 778 8440 for Vietnamese.
3. 3 Text QUITNOW to 333888 to start a text message support program, or text DEJELO YA to 333888 for the Spanish version.
4. 4 Smokefree.gov offers free online tools, with sections written for women, veterans, teens, Spanish speakers, and people over 60.
5. 5 The quitSTART app is a free smartphone tool listed on the same CDC page.
6. 6 CDC also names BecomeAnEX, run by the Truth Initiative, and YouCanQuit2, aimed at military members and their families.

None of these require insurance, a referral, or a diagnosis. If you are 62 and have smoked since you were 19, the over 60 section of Smokefree.gov was written with you in mind, and the quitline counselor will not be surprised by anything you tell them.

What a quitline call is actually like

Most people have never called one, so the idea stays abstract. A quitline is staffed by counselors trained specifically in tobacco cessation. The first call is usually longer than the rest and covers what you use, how much, what has happened in past attempts, and what you want to happen next. Then you and the counselor usually agree on a quit date and a schedule of follow up calls timed around it, because the first two weeks after a quit date are when most attempts come apart.

Two things are worth asking on that first call. Ask what the program includes besides phone calls, since many state programs add text support, online tools, or mailed materials. Ask whether your state program provides cessation medicine at no cost or reduced cost, because that varies from state to state and the counselor will know the answer for where you live.

Ask your health plan the same kind of question separately: what counseling and what cessation medicines are covered, and whether a prescription is needed for coverage even on products sold without one. These are questions, not assumptions. Coverage differs by plan and by state.

What the task force found, in plain numbers

The task force numbers are modest, and seeing them honestly is more useful than a motivational claim.

Among nonpregnant adults, brief advice from a doctor to stop using tobacco was followed by quitting in about 8 of every 100 people, compared with about 5 of every 100 who got no such advice. That is roughly 3 additional people out of 100 from a conversation that takes a few minutes. It is a real effect and a small one.

The size grows with contact. The task force reported that combined interventions typically involved at least 4 behavioral counseling sessions with 90 to 300 minutes of total contact time, and that the largest effects came from programs providing 8 or more sessions. This is the single most actionable finding in the whole recommendation. One conversation is a start. A course of eight calls is a plan. When a quitline counselor proposes a series of calls, the schedule itself is part of the treatment.

The behavioral approaches the task force reviewed include advice from a doctor, advice from a nurse, individual counseling with a cessation specialist, group programs, telephone counseling, and support delivered by mobile phone. Text message programs and quitlines are not a lesser substitute for real counseling. They are among the forms that were studied.

For pregnancy, the task force reached a Grade A conclusion for asking, advising, and providing behavioral counseling, and reported quitting in about 15 of every 100 people who received counseling compared with about 11 of every 100 in control groups. Its conclusion on cessation medicine during pregnancy was different: the evidence was judged insufficient to weigh benefits against harms. That is a distinction to raise directly with an obstetric health care professional rather than settle from a web page.

The medicines, described as categories

The task force named three categories of medicine approved by the FDA for quitting: nicotine replacement therapy, bupropion sustained release, and varenicline. CDC's page lists the nicotine replacement forms individually: patch, lozenge, gum, oral inhaler, and nasal spray. The CDC page also discusses using more than one of these medicines during the same period, an approach health care professionals sometimes use.

This article will not tell you which to use, and no article should. Some of these forms are sold without a prescription and some are not, and the answer differs by form. Which one fits depends on how much you use, how soon after waking you use it, what you have tried before, what else you take, and your other medical conditions. That is a conversation with a health care professional or a pharmacist, and pharmacists are often the easier appointment to get.

Bring your full medicine list to that conversation, including nonprescription medicines, vitamins, and supplements. The 2025 American Heart Association and American College of Cardiology high blood pressure guideline notes that about 20 percent of adults with high blood pressure regularly use nonprescription medicines that can raise blood pressure or interfere with treatment, so the list is worth having in your pocket anyway. A separate article in this series covers how to prepare for that conversation about smoking or nicotine use.

Electronic cigarettes, and why two respected sources disagree

This is the part where honest reporting requires dates.

In its January 2021 statement, the task force concluded that the evidence was insufficient to assess the balance of benefits and harms of electronic cigarettes for quitting in adults, including during pregnancy. That is a Grade I finding, which means not enough evidence to judge. It does not mean the devices were found ineffective, and it does not mean they were found unsafe. It means the question was open.

A Cochrane review of electronic cigarettes for stopping smoking, last updated January 1, 2026 and published August 26, 2026, reached a different position on the effectiveness question because it had far more evidence to work with. It included 90 completed studies, 49 of them randomized controlled trials, with 29,044 participants. Presented as whole people rather than percentages, the review reported that roughly 8 to 10 of every 100 people quit using nicotine electronic cigarettes, about 6 of every 100 using nicotine replacement therapy, and about 5 of every 100 with behavioral support alone or with no support. The comparison with nicotine replacement therapy carried a risk ratio of 1.59 with a 95 percent confidence interval of 1.30 to 1.93, and the review rated that evidence high certainty.

The review's other comparisons were rated less confidently, and the difference is worth understanding. Nicotine devices beat versions containing no nicotine, risk ratio 1.46 with a confidence interval of 1.09 to 1.96, rated moderate certainty. Compared with behavioral support alone or no support, the risk ratio was 1.96 with a confidence interval of 1.66 to 2.32, but Cochrane rated that evidence low certainty because of problems with how those studies were conducted. Certainty ratings describe how much the conclusion is likely to change as more research arrives, and they are not interchangeable.

The two conclusions are not a contradiction so much as a five year gap. The task force statement predates most of the randomized trials Cochrane included, and a recommendation is only as current as the evidence base underneath it. This is also a good example of a distinction that gets flattened in ordinary conversation. Insufficient evidence to judge something is a different finding from evidence that it does not work, and neither one is evidence that it is safe.

On safety within those trials, serious adverse events were rare across all groups, and the most commonly reported effects were throat and mouth irritation, headache, cough, and nausea. Those trials were designed to measure whether people stopped smoking, usually over months rather than decades. They are not a long term safety study of continued use, and a high certainty finding about quit rates is not a finding that the devices are safe.

Nothing here is a recommendation to use them. The reason to know both sources is so you can have a real conversation with a health care professional instead of a debate with the internet. Anyone weighing this should raise it directly, along with what they have already tried and what happened.

What stopping does and does not do to your readings

Two separate blood pressure facts get tangled together here, and separating them helps.

The first is about the number on the cuff in the next ten minutes. A 2017 systematic review of measurement error found that acute nicotine was associated with systolic readings 2.8 to 25 mm Hg higher and diastolic readings 2 to 18 mm Hg higher. This is why the standard measurement checklist calls for no smoking, caffeine, or exercise for at least 30 minutes before a reading. A reading taken on the porch right after a cigarette is a measurement problem, not a picture of your blood pressure. That rule applies to any nicotine product, including vaping devices and pouches, not just cigarettes.

The second is about long term risk, and here expectations should be set carefully. The 2025 American Heart Association and American College of Cardiology guideline includes a table of lifestyle changes with estimated effects on systolic blood pressure, covering weight loss, eating pattern, sodium, potassium, alcohol reduction, exercise, and stress techniques. Stopping tobacco is not on that list. That absence is not a verdict on its importance. The American Heart Association describes smoking as the most important preventable cause of premature death in the United States, and its benefit shows up mainly in the arteries, the heart, and the lungs rather than as a predictable drop in the cuff number.

So it is fair to expect that stopping tobacco reduces cardiovascular risk, and unfair to expect that it moves your home readings by a set amount. If someone stops and their readings barely change, that is not a sign the effort was wasted.

If a quit attempt ends early

Returning to tobacco after a quit date is common enough that programs are built around it rather than surprised by it. The quitline does not charge more the second time. A health care professional conversation about a different medicine, or about adding counseling to a medicine that was tried alone, is a normal follow up rather than an admission of failure.

The most useful thing to carry out of an attempt that ended is specific information: what day it fell apart, what was happening at the time, whether any medicine was being used and whether it was used as directed, and what the first few hours after the first cigarette felt like. That detail is exactly what a counselor uses to build the next plan, and it is far more useful than a general sense that it did not work.

One boundary worth stating plainly. Decide on your own to call the quitline, sign up for the text program, or download the app. Do not decide on your own to start, stop, combine, or change the dose of any cessation medicine, particularly if you take medicine for blood pressure or any heart condition. Those choices belong in a conversation with a health care professional or a pharmacist who can see your whole list.